they argued that promoter switching may be correlated with cancer development and progression regardless of additional mutations. What evidence did they have to support this idea ?

Human Anatomy & Physiology (11th Edition)
11th Edition
ISBN:9780134580999
Author:Elaine N. Marieb, Katja N. Hoehn
Publisher:Elaine N. Marieb, Katja N. Hoehn
Chapter1: The Human Body: An Orientation
Section: Chapter Questions
Problem 1RQ: The correct sequence of levels forming the structural hierarchy is A. (a) organ, organ system,...
icon
Related questions
Question
100%
In Demircioglu et al (2019), the authors found that promoter switching for the ERBB2 gene was
often associated with mutations in other known oncogenes and tumor suppresor genes. However,
they argued that promoter switching may be correlated with cancer development and progression
regardless of additional mutations. What evidence did they have to support this idea ?
O They found that patients who had ERBB2 promoter switching but no other mutations in known oncogenes
(OG) and tumor suppressor genes (TSG) carried many other mutations in genes that may have contributed to
cancer progression and had not been identified as OG or TSG yet.
O They saw that patients that showed promoter switching but did not have any other identifiable mutations had
poorer prognosis than patients without promoter switching
This was actually a discussion point; the authors did not have any experimental evidence to support their
claim.
O They treated all patients that showed promoter switching with the same drug and saw that they responded
similarly
O They found that patients with the mutations in the known oncogenes and tumor suppressor genes had overall
worse prognosis than the general population
Transcribed Image Text:In Demircioglu et al (2019), the authors found that promoter switching for the ERBB2 gene was often associated with mutations in other known oncogenes and tumor suppresor genes. However, they argued that promoter switching may be correlated with cancer development and progression regardless of additional mutations. What evidence did they have to support this idea ? O They found that patients who had ERBB2 promoter switching but no other mutations in known oncogenes (OG) and tumor suppressor genes (TSG) carried many other mutations in genes that may have contributed to cancer progression and had not been identified as OG or TSG yet. O They saw that patients that showed promoter switching but did not have any other identifiable mutations had poorer prognosis than patients without promoter switching This was actually a discussion point; the authors did not have any experimental evidence to support their claim. O They treated all patients that showed promoter switching with the same drug and saw that they responded similarly O They found that patients with the mutations in the known oncogenes and tumor suppressor genes had overall worse prognosis than the general population
Expert Solution
steps

Step by step

Solved in 2 steps

Blurred answer
Knowledge Booster
Genomic studies
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, biology and related others by exploring similar questions and additional content below.
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
Human Anatomy & Physiology (11th Edition)
Human Anatomy & Physiology (11th Edition)
Biology
ISBN:
9780134580999
Author:
Elaine N. Marieb, Katja N. Hoehn
Publisher:
PEARSON
Biology 2e
Biology 2e
Biology
ISBN:
9781947172517
Author:
Matthew Douglas, Jung Choi, Mary Ann Clark
Publisher:
OpenStax
Anatomy & Physiology
Anatomy & Physiology
Biology
ISBN:
9781259398629
Author:
McKinley, Michael P., O'loughlin, Valerie Dean, Bidle, Theresa Stouter
Publisher:
Mcgraw Hill Education,
Molecular Biology of the Cell (Sixth Edition)
Molecular Biology of the Cell (Sixth Edition)
Biology
ISBN:
9780815344322
Author:
Bruce Alberts, Alexander D. Johnson, Julian Lewis, David Morgan, Martin Raff, Keith Roberts, Peter Walter
Publisher:
W. W. Norton & Company
Laboratory Manual For Human Anatomy & Physiology
Laboratory Manual For Human Anatomy & Physiology
Biology
ISBN:
9781260159363
Author:
Martin, Terry R., Prentice-craver, Cynthia
Publisher:
McGraw-Hill Publishing Co.
Inquiry Into Life (16th Edition)
Inquiry Into Life (16th Edition)
Biology
ISBN:
9781260231700
Author:
Sylvia S. Mader, Michael Windelspecht
Publisher:
McGraw Hill Education